Excelsior Medical Co., Ltd. (4104.TW)
TWD 84.9
(6.26%)
TWD 84.9
(6.26%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 18.07 Billion TWD | 9.69% |
| 2022 | 16.48 Billion TWD | 9.12% |
| 2021 | 15.1 Billion TWD | 7.86% |
| 2020 | 14 Billion TWD | 1.74% |
| 2019 | 13.76 Billion TWD | -1.54% |
| 2018 | 13.98 Billion TWD | -6.49% |
| 2017 | 14.95 Billion TWD | -11.14% |
| 2016 | 16.82 Billion TWD | 7.75% |
| 2015 | 15.61 Billion TWD | 4.92% |
| 2014 | 14.88 Billion TWD | 4.87% |
| 2013 | 14.19 Billion TWD | 8.42% |
| 2012 | 13.08 Billion TWD | 4.62% |
| 2011 | 12.51 Billion TWD | 7.03% |
| 2010 | 11.68 Billion TWD | 27.96% |
| 2009 | 9.13 Billion TWD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 18.41 Billion TWD | 1.85% |
| 2024 Q2 | 17.69 Billion TWD | -3.93% |
| 2023 Q4 | 18.07 Billion TWD | 2.84% |
| 2023 FY | 18.07 Billion TWD | 9.69% |
| 2023 Q1 | 16.72 Billion TWD | 1.48% |
| 2023 Q2 | 16.94 Billion TWD | 1.32% |
| 2023 Q3 | 17.58 Billion TWD | 3.74% |
| 2022 Q4 | 16.48 Billion TWD | 1.56% |
| 2022 FY | 16.48 Billion TWD | 9.12% |
| 2022 Q2 | 16.01 Billion TWD | 3.87% |
| 2022 Q1 | 15.41 Billion TWD | 2.07% |
| 2022 Q3 | 16.22 Billion TWD | 1.34% |
| 2021 FY | 15.1 Billion TWD | 7.86% |
| 2021 Q3 | 14.52 Billion TWD | -0.61% |
| 2021 Q4 | 15.1 Billion TWD | 3.96% |
| 2021 Q1 | 14.26 Billion TWD | 1.89% |
| 2021 Q2 | 14.61 Billion TWD | 2.45% |
| 2020 Q3 | 13.76 Billion TWD | -0.61% |
| 2020 Q4 | 14 Billion TWD | 1.71% |
| 2020 FY | 14 Billion TWD | 1.74% |
| 2020 Q2 | 13.85 Billion TWD | -4.56% |
| 2020 Q1 | 14.51 Billion TWD | 5.45% |
| 2019 Q3 | 13.92 Billion TWD | -4.76% |
| 2019 Q2 | 14.61 Billion TWD | 0.75% |
| 2019 Q1 | 14.5 Billion TWD | 3.76% |
| 2019 Q4 | 13.76 Billion TWD | -1.12% |
| 2019 FY | 13.76 Billion TWD | -1.54% |
| 2018 Q2 | 14.77 Billion TWD | -1.72% |
| 2018 Q4 | 13.98 Billion TWD | 0.71% |
| 2018 FY | 13.98 Billion TWD | -6.49% |
| 2018 Q1 | 15.03 Billion TWD | 0.56% |
| 2018 Q3 | 13.88 Billion TWD | -6.06% |
| 2017 Q3 | 14.63 Billion TWD | -3.92% |
| 2017 FY | 14.95 Billion TWD | -11.14% |
| 2017 Q4 | 14.95 Billion TWD | 2.14% |
| 2017 Q2 | 15.23 Billion TWD | 0.41% |
| 2017 Q1 | 15.17 Billion TWD | -9.83% |
| 2016 Q2 | 16.33 Billion TWD | 0.51% |
| 2016 Q1 | 16.25 Billion TWD | 4.09% |
| 2016 FY | 16.82 Billion TWD | 7.75% |
| 2016 Q4 | 16.82 Billion TWD | 3.88% |
| 2016 Q3 | 16.19 Billion TWD | -0.85% |
| 2015 FY | 15.61 Billion TWD | 4.92% |
| 2015 Q1 | 14.57 Billion TWD | -2.07% |
| 2015 Q4 | 15.61 Billion TWD | 2.09% |
| 2015 Q2 | 15.25 Billion TWD | 4.7% |
| 2015 Q3 | 15.29 Billion TWD | 0.25% |
| 2014 FY | 14.88 Billion TWD | 4.87% |
| 2014 Q2 | 14.53 Billion TWD | 2.98% |
| 2014 Q3 | 13.82 Billion TWD | -4.86% |
| 2014 Q4 | 14.88 Billion TWD | 7.65% |
| 2014 Q1 | 14.11 Billion TWD | -0.57% |
| 2013 Q3 | 13.84 Billion TWD | -1.33% |
| 2013 Q4 | 14.19 Billion TWD | 2.51% |
| 2013 FY | 14.19 Billion TWD | 8.42% |
| 2013 Q2 | 14.03 Billion TWD | 2.42% |
| 2013 Q1 | 13.69 Billion TWD | 4.66% |
| 2012 Q1 | 12.92 Billion TWD | 3.29% |
| 2012 FY | 13.08 Billion TWD | 4.62% |
| 2012 Q4 | 13.08 Billion TWD | -1.65% |
| 2012 Q3 | 13.3 Billion TWD | 0.83% |
| 2012 Q2 | 13.19 Billion TWD | 2.14% |
| 2011 Q3 | 14.04 Billion TWD | 9.19% |
| 2011 Q1 | 12.4 Billion TWD | 6.1% |
| 2011 Q2 | 12.86 Billion TWD | 3.71% |
| 2011 Q4 | 12.51 Billion TWD | -10.91% |
| 2011 FY | 12.51 Billion TWD | 7.03% |
| 2010 Q4 | 11.68 Billion TWD | 0.0% |
| 2010 FY | 11.68 Billion TWD | 27.96% |
| 2009 FY | 9.13 Billion TWD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Apex Medical Corp. | 3.22 Billion TWD | -460.645% |
| OK Biotech Co., Ltd. | 3.06 Billion TWD | -489.43% |
| Applied BioCode Corporation | 993.2 Million TWD | -1720.358% |